-

Fortune Ranks Agilent Among Top Workplaces in Health Care

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the company has been named a “Best Workplace in Health Care” in the United States by Fortune magazine. Agilent’s number 17 ranking is based on the Great Place to Work® employee survey and company-provided data.

Eighty-five percent of Agilent employees who responded to the survey indicated that the company is a great place to work, compared to 57 percent of employees at a typical U.S.-based company, reported Fortune.

“We are pleased to receive this recognition from Fortune, which is particularly meaningful because it is based on the experience of our employees,” said Agilent President and CEO Mike McMullen. “A strong culture and our team are what drives our performance and our success, and I am grateful to the thousands of employees who work every day to make this a great workplace.”

Employees also gave the company high marks on ethical business practices, work-life balance, and community engagement. Ninety percent reported that they are proud to work at Agilent.

Agilent’s 2021 Environmental, Social, and Governance report highlights a variety of initiatives that contribute to a positive employee experience, from paid time off for volunteering and flexible working arrangements to a comprehensive talent development program and employee networking groups that foster a sense of community.

This recognition builds on other recent Agilent workplace awards, including a Forbes 2021 Top 100 Female Friendly Company, Barron’s 2021 #2 Most Sustainable Company, Great Place to Work 2021 US, and Forbes 2021 Best Employers for Diversity.

Learn more about Agilent’s culture, diversity and inclusion program, and careers.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in the life sciences, diagnostics, and applied chemical markets, delivering insight and innovation that advance the quality of life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.32 billion in fiscal 2021 and employs 17,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter and Facebook.

Contacts

Sarah Litton
+1 669 255 7696
sarah.litton@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions
$Cashtags

Contacts

Sarah Litton
+1 669 255 7696
sarah.litton@agilent.com

Social Media Profiles
More News From Agilent Technologies Inc.

Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and production.The new SEC and PLRP-S columns support critical analytical workflows across a range of biotherapeutic modalities, including peptides, proteins, oligonucleotides...

Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software upgrade enhances the unique dual-readout capabilities of the Agilent xCELLigence RTCA eSight instrument with AI-driven cell imaging analysis, enabling researchers to...

Agilent Completes Acquisition of Biocare Medical

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction, Biocare is now part of Agilent’s Life Sciences and Diagnostics Markets Group.“We are pleased to complete our acquisition of Biocare, which represents a natural and st...
Back to Newsroom